{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:35:41Z","timestamp":1791218141790,"version":"4.1.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3,13]]},"DOI":"10.1097\/qad.0b013e328327964f","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T11:14:23Z","timestamp":1242904463000},"page":"631-636","source":"Crossref","is-referenced-by-count":181,"title":["Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort"],"prefix":"10.1097","volume":"23","author":[{"given":"Jonathan E","family":"Golub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Pronyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lerato","family":"Mohapi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nkeko","family":"Thsabangu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mosa","family":"Moshabela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Struthers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda E","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E","family":"Chaisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil A","family":"Martinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210130","first-page":"935","article-title":"A controlled trial of community-wide isoniazid prophylaxis in Alaska","volume":"95","author":"Comstock","year":"1967","journal-title":"Am Rev Respir Dis"},{"key":"R4-10-20210130","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0140-6736(93)91817-6","article-title":"Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection","volume":"342","author":"Pape","year":"1993","journal-title":"Lancet"},{"key":"R5-10-20210130","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1097\/00002030-199818000-00014","article-title":"Twice weekly tuberculosis preventive therapy in HIV infection in Zambia","volume":"12","author":"Mwinga","year":"1998","journal-title":"AIDS"},{"key":"R6-10-20210130","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM199709183371201","article-title":"A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration","volume":"337","author":"Whalen","year":"1997","journal-title":"N Engl J Med"},{"key":"R7-10-20210130","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1097\/00002030-200309260-00007","article-title":"Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?","volume":"17","author":"Churchyard","year":"2003","journal-title":"AIDS"},{"key":"R8-10-20210130","first-page":"CD000171","article-title":"Treatment of latent tuberculosis infection in HIV infected persons.","volume":"1","author":"Woldehanna","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"R9-10-20210130","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00002030-199903110-00009","article-title":"Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials","volume":"13","author":"Bucher","year":"1999","journal-title":"AIDS"},{"key":"R12-10-20210130","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(02)08904-3","article-title":"Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study","volume":"359","author":"Badri","year":"2002","journal-title":"Lancet"},{"key":"R13-10-20210130","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1086\/338641","article-title":"Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy","volume":"34","author":"Santoro-Lopes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R14-10-20210130","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1097\/00002030-200009080-00015","article-title":"Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection","volume":"14","author":"Girardi","year":"2000","journal-title":"AIDS"},{"key":"R15-10-20210130","first-page":"1026","article-title":"HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult\/Adolescent Spectrum of HIV Disease Group","volume":"4","author":"Jones","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"key":"R16-10-20210130","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1097\/01.aids.0000194808.20035.c1","article-title":"Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort","volume":"19","author":"Lawn","year":"2005","journal-title":"AIDS"},{"key":"R17-10-20210130","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.aids.0000238406.93249.cd","article-title":"Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control","volume":"20","author":"Lawn","year":"2006","journal-title":"AIDS"},{"key":"R18-10-20210130","first-page":"769","article-title":"Tuberculosis as primary cause of death among AIDS cases in Rio de Janeiro, Brazil","volume":"12","author":"Saraceni","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"R19-10-20210130","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/QAD.0b013e328216f441","article-title":"The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil","volume":"21","author":"Golub","year":"2007","journal-title":"AIDS"},{"key":"R21-10-20210130","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(97)06532-X","article-title":"Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection","volume":"351","author":"Halsey","year":"1998","journal-title":"Lancet"},{"key":"R22-10-20210130","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/bmj.317.7159.625","article-title":"Effect of preventive treatment for tuberculosis in adults infected with HIV: systematic review of randomised placebo controlled trials","volume":"317","author":"Wilkinson","year":"1998","journal-title":"BMJ"},{"key":"R24-10-20210130","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3201\/eid1205.050681","article-title":"Isoniazid preventive therapy and risk for resistant tuberculosis","volume":"12","author":"Balcells","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"R25-10-20210130","first-page":"263","article-title":"Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: implications for antiretroviral delivery in resource-poor settings?","volume":"9","author":"Rowe","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"key":"R27-10-20210130","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/QAD.0b013e328013f632","article-title":"Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda","volume":"21","author":"Moore","year":"2007","journal-title":"AIDS"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-200903130-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:54:18Z","timestamp":1786038858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200903130-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,13]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328327964f","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3,13]]}}}